The Big Idea: The coxib crisis Iron, aspirin and heart disease risk revisited

Journal of the Royal Society of Medicine

Volumn 100, Issue 7, 2007, Pages 346-349

  Sullivan, Jerome L ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETORICOXIB; IRON; ROFECOXIB;

BLEEDING; CARDIOVASCULAR RISK; DOSE RESPONSE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HEART PROTECTION; HUMAN; IRON DEFICIENCY; IRON DEPLETION; LONG TERM CARE; PROPHYLAXIS; REVIEW; SURVIVAL RATE;

EID: 34547128868     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.100.7.346     Document Type: Review

References (20)

1. Kuhn TS. The Structure of Scientific Revolutions. 2nd edition. Chicago: University of Chicago Press, 1970
2. Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 2005;112:759-70
3. Topol EJ. Arthritis medicines and cardiovascular events - 'House of Coxibs'. JAMA 2005;293:366-8
4. Sullivan JL. Iron, aspirin, and heart disease risk [letter]. JAMA 1982;247:751
5. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4
6. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-88
7. Sullivan JL. Stored Iron and Vascular Reactivity. Arterioscler Thromb Vasc Biol 2005;25:1532-5
8. Sullivan J. Is stored iron safe? J Lab Clin Med 2004;144:280-4
9. Milman N, Ovesen L, Byg K, Graudal N. Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence Of blood donation, alcohol intake, and iron supplementation. Ann Hematol 1999;78:393-400
10. Liu JM, Hankinson SE, Stampfer MJ, Rifai N, Willett WC, Ma J. Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr 2003;78:1160-7
11. Fleming DJ, Jacques PF, Massaro JM, D'Agostino RB Sr, Wilson PW, Wood RJ. Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr 2001;74:219-26
12. Kaffes A, Cullen J, Mitchell H, Katelaris PH. Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly. J Gastroenterol Hepatol 2003;18:1024-8
13. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998;316:1337-43
14. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of Nonsteroidal antiinflammatory drugs. An update for clinicians. A scientific statement from the American Heart Association. Circulation 2007;115:[DOI: 10.1161/CIRCULATIONAHA.106.181424]
15. Dobson R. NEJM 'failed its readers' by delay in publishing its concerns about VIGOR trial. BMJ 2006;333:116
16. Cannon CP, Curtis SP, Bolognese JA, Laine L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. Am Heart J 2006;152:237-45
17. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55
18. Lapenna D, Pierdomenico SD, Ciofani G, et al. Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radical Biol Med 2007;42:492-8
19. Zacharski LR, Chow BK, Howes PS, et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007;297:603-10
20. CLIPS Group. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 2007;261:276-84